title: Inflammatory markers should be assessed together with cardiovascular risk factors by clinicians in masked hypertension.
authors.forename: Sevket
authors.initials: S
authors.lastname: Balta
authors.forename: Sait
authors.initials: S
authors.lastname: Demirkol
authors.forename: Turgay
authors.initials: T
authors.lastname: Celik
authors.forename: Murat
authors.initials: M
authors.lastname: Unlu
authors.forename: Ugur
authors.initials: U
authors.lastname: Kucuk
authors.forename: Zekeriya
authors.initials: Z
authors.lastname: Arslan
mesh_terms: D050197:Atherosclerosis / Q000097:blood*; D005260:Female; D006801:Humans; D036341:Intercellular Signaling Peptides and Proteins / Q000097:blood*; D008297:Male; D059468:Masked Hypertension / Q000097:blood*; D012065:Relaxin / Q000097:blood*
chemical_list: D036341:Intercellular Signaling Peptides and Proteins; D012065:Relaxin